Precision Biosensor Inc
KOSDAQ:335810
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Precision Biosensor Inc
Gross Profit
Precision Biosensor Inc
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Precision Biosensor Inc
KOSDAQ:335810
|
Gross Profit
₩6.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Gross Profit
₩129.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
|
SD Biosensor Inc
KRX:137310
|
Gross Profit
₩339.4B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Gross Profit
₩42.6B
|
CAGR 3-Years
22%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Gross Profit
₩27.7B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
22%
|
CAGR 10-Years
16%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Gross Profit
₩75.5B
|
CAGR 3-Years
35%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
|
Precision Biosensor Inc
Glance View
Precision Biosensor, Inc. develops in-vitro diagnostics technology that provides advanced diagnostic solutions. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2020-12-22. The firm's main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The firm sells its products in domestic and overseas markets such as Europe, China, the Middle East, and Southeast Asia.
See Also
What is Precision Biosensor Inc's Gross Profit?
Gross Profit
6.2B
KRW
Based on the financial report for Dec 31, 2024, Precision Biosensor Inc's Gross Profit amounts to 6.2B KRW.
What is Precision Biosensor Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
17%
Over the last year, the Gross Profit growth was -20%. The average annual Gross Profit growth rates for Precision Biosensor Inc have been 10% over the past three years , 17% over the past five years .
